Skip to main content
. 2021 Mar 16;14(3):267. doi: 10.3390/ph14030267

Figure 3.

Figure 3

(a) H&E staining of livers, RWAT, and EWAT (magnification, 200×) and changes in (b) fatty liver score and the sizes of (c) RWAT and (d) EWAT adipocytes in control and doxepin-treated obese mice over 56 treatment days. All values denote the mean ± standard deviation (n = 10 for all groups). *** p < 0.001 indicate very high statistical significance.